Bioceres Crop Solutions faces damages awarded by a New York court, together with $1.4 million in costs and attorneys’ fees and per diem interest from July 23, 2026, until judgment. The company and guarantor defendants intend to appeal, giving investors a stated legal award and next procedural step.
Key Highlights
- Per diem interest applies from July 23, 2026, through the date judgment is entered.
- The proceeding involved Jasper Lake Ventures One LLC and other plaintiffs under index No. 659704/2025.
- A New York court granted the plaintiffs’ request, and the damages amount was set out in their motion papers.
- Bioceres identified an appeal as the next legal step after the ruling; CEO Federico Trucco signed the report on September 18, 2026.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a Chemicals: Agricultural company. The proceeding involved Jasper Lake Ventures One LLC and other plaintiffs, with the matter identified as Index No. 659704/2025.
New York Court Sets Damages Award
011, and granted that request. The damages amount was set out in the plaintiffs’ motion papers. The case names Bioceres Crop Solutions Corp. among the defendants.
Appeal Intended After Court Ruling
That stated appeal is the next legal step identified by the company. Federico Trucco signed the report for Bioceres Crop Solutions Corp. as Chief Executive Officer on September 18, 2026. V.
FAQs
Q: When does interest apply in the Bioceres Crop Solutions case?
A: Per diem interest applies beginning July 23, 2026. It continues until the court enters judgment in the legal proceeding.
Q: Will Bioceres Crop Solutions appeal the court ruling?
A: The stated appeal follows the New York court’s damages decision.
Q: Who were the plaintiffs in the proceeding?
A: The proceeding involved Jasper Lake Ventures One LLC and other plaintiffs.
Q: What was the matter’s index number?
A: The matter was identified as Index No. 659704/2025.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.